Learn More About Power

Why We Started Power

We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.

Bask
Bask GillCEO at Power
Learn More About Trials
How Do Clinical Trials Work?Are Clinical Trials Safe?What Can I Expect During a Clinical Trial?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
1045 Sansome St, Suite 321, San Francisco, CA
hello@withpower.com(415) 900-4227
About UsClinical Trials by ConditionAll Clinical TrialsWork With Us
1
Directories
Conditions
Cities
States
Popular Categories
Depression & Anxiety
Neurology
Psychiatry
Pain
Metabolism
Treatments
Locations
Florida
New Jersey
North Carolina
Texas
Ohio
California
Pennsylvania
Kentucky
New York
Indiana
Psychology Related
Depression
Schizophrenia
Anxiety
PTSD
ADHD
Autism
Bipolar Disorder
Addiction
OCD
Eating Disorder
Treatments
Psilocybin
IVF
Dental Implant
Weight Loss
Smoking
Platelet-Rich Plasma
Testosterone
Saxenda
Melatonin
Entresto
Cities
Saint Louis
Columbus
Portland
Ann Arbor
Aurora
Salt Lake City
Rochester
Birmingham
Detroit
New Haven
Terms of Service·Privacy Policy·Cookies
Cookies & Data Use Policy

At Power, we believe in using data responsibly to help you find the right clinical trials — without compromising your privacy. This page explains how we use cookies and personal data across www.withpower.com.

Before You Create a Profile

When you browse Power's website, you're opting in to our use of cookies. Cookies are used to improve your experience and help us understand how the site is used so that we can make improvements for you in the future. Specifically, we use cookies to:

Personalize Your Experience

We use cookies to customize your visit based on basic information like your general location (determined by your IP address). This allows us to:

  • Show you clinical trials that are geographically relevant to you
  • Tailor search results to match the conditions or keywords you've explored before
  • Pre-fill certain fields or remember your previous searches, so you don't have to repeat them

Save Your Preferences

We remember what you interact with during your visit — for example:

  • The conditions you search for
  • Whether you prefer certain types of studies (e.g., paid trials, trials for a specific age group)
  • Your sorting or filtering preferences when browsing trials

This helps us make your experience more efficient and personalized the next time you visit.

Understand How the Site Is Used

Cookies help us collect anonymous usage data so we can make Power better. We use these insights to:

  • Monitor how users move through the site — for example, which pages get the most traffic and where users tend to exit
  • Track how long visitors stay on each page and whether they find what they’re looking for
  • Identify points of friction or confusion so we can improve usability
  • Test design changes (like different page layouts or buttons) and measure which version performs better
  • Detect and fix bugs or slow-loading pages to maintain site reliability

These analytics are aggregated and do not include personal identifiers. We use tools like Google Analytics to process this data, but we don't use it to target ads or sell your information.

We do not:

  • Sell or share your personal data with advertisers
  • Use your behavior on our site to target you with third-party ads

All cookie use is designed to support your experience on Power — never to track you across the internet or monetize your information.

After You Create a Profile

When you sign up for a Power account, you agree to our Privacy Policy and Terms of Service. Creating a profile allows us to better serve you by tailoring the platform to your specific needs.

Once you create a profile:

  • We may collect additional information about your health and clinical interests to help us match you to the most relevant studies.
  • We continue to use cookies to remember your session, keep you logged in, and personalize your dashboard.
  • You have full control — you can delete your profile at any time, and we'll remove your personal data in accordance with our privacy practices.

We use your data solely to fulfill our mission: helping you find clinical trials that could be a fit — not for advertising or resale.

·Security
Condition
Suggested Conditions
  • Anxiety
  • Depression
  • Alzheimer's Disease
  • Weight Loss
  • Heart Disease
  • Cancer
  • Asthma
Location

    Myopia

    Current Location

    Search
    Myopia
    Show Map
    Map View
    Your Location

    Popular Searches

    By Condition

    Depression Clinical Trials

    Anxiety Clinical Trials

    Schizophrenia Clinical Trials

    ADHD Clinical Trials

    Bipolar Disorder Clinical Trials

    Multiple Sclerosis Clinical Trials

    Autism Clinical Trials

    Treatment Resistant Depression Clinical Trials

    Borderline Personality Disorder Clinical Trials

    Social Anxiety Disorder Clinical Trials

    Parkinson's Disease Clinical Trials

    Alzheimer's Disease Clinical Trials

    By Location

    Clinical Trials in California

    Clinical Trials in Florida

    Clinical Trials in Texas

    Clinical Trials in New York

    Clinical Trials in Ohio

    Clinical Trials in Illinois

    Clinical Trials in Pennsylvania

    Clinical Trials in Michigan

    Clinical Trials in North Carolina

    Clinical Trials in Massachusetts

    Clinical Trials in Missouri

    Clinical Trials in Minnesota

    Other People Viewed

    By Subject

    156 Clinical Trials near Granville, OH

    183 Clinical Trials near Buena Park, CA

    227 Clinical Trials near Rochester, MN

    160 Clinical Trials near Columbus, OH

    183 Clinical Trials near Palo Alto, CA

    Top Achalasia Clinical Trials

    Top Anorexia Clinical Trials

    Top Mci Clinical Trials

    Top Breast Clinical Trials

    Top Prostatitis Clinical Trials

    Top Glaucoma Clinical Trials

    Top Ctcl Clinical Trials

    By Trial

    Intranasal Capsaicinoid Spray for Allergic Rhinitis

    New Full-Face Mask for Respiratory Failure

    Digital Self-Management for Childhood Cancer Survivors

    Face-Down Positioning Duration for Macular Hole Repair

    OpCT-001 for Retinitis Pigmentosa

    Safety of N-13 Ammonia PET MPI

    Massage Therapy for Premature Babies

    CureSight for Lazy Eye

    Atropine Eye Drops for Near-Sightedness

    MiSight 1 Day Contact Lenses for Nearsightedness

    Foot Rehab + Minimalist Shoes for Plantar Fasciitis

    Multiplexing Prism for Monocular Vision

    Related Searches

    Top Alzheimers-disease Clinical Trials near Las Vegas, NV

    HP 129Xe MRI for Lung Transplant Rejection

    Mightier Video Games for Emotional Dysregulation

    Digital Cognitive Rehabilitation for Sickle Cell Disease

    Inotuzumab + Venetoclax + Dexamethasone for Acute Lymphoblastic Leukemia

    Vytorin for Prostate Cancer

    CD200AR-L + Vaccine for Brain Tumors

    Cross-Education Strength Training for Post-Meniscus Surgery Recovery

    DS-3939a for Advanced Solid Tumors

    Cognitive Behavioral Therapy for PTSD

    Top Clinical Trials near Delaware, OH

    DF6215 for Solid Tumors

    Search Clinical Trials
    Conditions
    Suggestions
    • Anxiety
    • Depression
    • Alzheimer's Disease
    • Weight Loss
    • Heart Disease
    • Cancer
    • Asthma
    Locations
    Suggestions
      Treatment Type
      Suggestions
      • Cognitive Behavioral Therapy
      • Medication Management
      • Group Therapy
      • Psychotherapy
      • Mindfulness-Based Therapy
      • Exposure Therapy

      Trial Phase

      Trial Status

      Paid Participation

      Clear All

      Filters

      0

      Suggestions
      • Cognitive Behavioral Therapy
      • Medication Management
      • Group Therapy
      • Psychotherapy
      • Mindfulness-Based Therapy
      • Exposure Therapy

      Paid Participation

      Trial Status

      Trial Phase

      Clear All
      Why We Started Power

      We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.

      Bask
      Bask GillCEO at Power
      Learn More About Trials
      How Do Clinical Trials Work?Are Clinical Trials Safe?What Can I Expect During a Clinical Trial?

      36 Myopia Trials Near You

      Power is an online platform that helps thousands of Myopia patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.

      Learn More About Power
      No Placebo
      Highly Paid
      Stay on Current Meds
      Pivotal Trials (Near Approval)
      Breakthrough Medication

      Atropine Eye Drops for Near-Sightedness

      Rockville, Maryland
      This trial is testing special eye drops with a tiny amount of atropine to see if they can slow down worsening nearsightedness in children. The drops work by relaxing eye muscles and slowing down changes in the eye. Lower doses of atropine have shown effectiveness with fewer side effects.
      Pivotal Trial (Near Approval)

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Phase 3
      Age:3 - 15

      Key Eligibility Criteria

      Disqualifiers:Ocular Inflammation, Myopia Control Treatment, Refractive Surgery, Others

      678 Participants Needed

      MiSight 1 Day Contact Lenses for Near-sightedness

      Rockville, Maryland
      The purpose of this post-approval study is to confirm the safety of daily disposable soft contact lens wear among the intended patient population for the MiSight 1 Day lens in the US.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:8 - 12

      Key Eligibility Criteria

      Disqualifiers:Eye Infections, Dry Eyes, Others
      Must Not Be Taking:Myopia Control Drugs

      2400 Participants Needed

      SYD-101 for Myopia

      Bala-Cynwyd, Pennsylvania
      This trial is testing SYD-101 eye drops to see if they can slow down nearsightedness in children. The goal is to prevent their eyesight from getting worse too quickly and reduce future eye problems.
      Pivotal Trial (Near Approval)

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Phase 3
      Age:3 - 14

      Key Eligibility Criteria

      Disqualifiers:Not Listed

      852 Participants Needed

      Atropine Eye Drops for Near-Sightedness

      Philadelphia, Pennsylvania
      This trial tests eye drops with small amounts of atropine on people with nearsightedness. It aims to see if the drops can slow down the worsening of their vision by affecting how their eyes grow. Low-dose atropine (0.01%) has been proven to be an effective and safe treatment for slowing the progression of myopia with negligible side effects.
      Pivotal Trial (Near Approval)

      Trial Details

      Trial Status:Active Not Recruiting
      Age:3 - 12

      Key Eligibility Criteria

      Disqualifiers:Not Listed

      420 Participants Needed

      MiSight 1 Day Contact Lenses for Nearsightedness

      Chesapeake, Virginia
      This trial is testing special contact lenses called MiSight 1 Day to see if they can slow down worsening nearsightedness in children. The study will also check if the benefits last after stopping the treatment. The lenses work by changing how light enters the eye to slow down eye growth. MiSight 1 Day contact lenses have been shown to slow myopia progression in children over several years.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:8 - 12

      Key Eligibility Criteria

      Disqualifiers:Ocular Disease, Dry Eyes, Keratoconus, Others
      Must Not Be Taking:Myopia Control, Systemic, Topical

      900 Participants Needed

      DG1 Spectacle Lens for Near-sightedness

      Virginia Beach, Virginia
      The goal of this clinical trial is to evaluate the safety and efficacy of the DG1 spectacle lens for myopia progression control in children. * To assess if the DG1 lens will slow the progression of myopia through an adjusted mean difference (e.g., age and baseline SER) of approximately 0.75D in cycloplegic spherical equivalent autorefraction refractive error compared to single-vision (SV) spectacles over the study period. * To assess if DG1 lens will slow the progression of myopia through an adjusted mean difference (e.g., age and baseline SER) of approximately 0.3mm in axial elongation compared to SV over the study period. The clinical trial will compare DG1 spectacle lens to single vision spectacle lens. Participants will wear spectacle lenses and return for visits at regularly scheduled intervals through a 36-month follow up visit. All subjects who complete the 36-month visit will continue in the study for an additional 12 months for the rebound evaluation.

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:7 - 10

      Key Eligibility Criteria

      Disqualifiers:Strabismus, Amblyopia, Pathological Myopia, Others
      Must Not Be Taking:Atropine

      240 Participants Needed

      Orthokeratology Lenses for Near-sightedness

      North Brunswick, New Jersey
      Lens wettability and subjective comfort of Euclid orthokeratology lenses with and without an enhanced coating will be compared in 50 children. Axial elongation will be monitored in pediatric patients who qualify and consent.
      No Placebo Group

      Trial Details

      Trial Status:Not Yet Recruiting
      Trial Phase:Unphased
      Age:6 - 35

      Key Eligibility Criteria

      Disqualifiers:Pregnancy, Autoimmune, Diabetes, Strabismus, Others
      Must Not Be Taking:Corticosteroids, Antimetabolites

      50 Participants Needed

      Multifocal Contact Lenses for Near-Sightedness

      New York, New York
      This is a multi-center, randomized, double-masked clinical trial. All study devices are market approved/cleared in the localities where the study is conducted. Subjects will be randomly assigned to wear NaturalVue Sphere single vision contact lenses (SVCL) or NaturalVue Multifocal (NVMF) soft contact lenses for a total of three years.

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:7 - 13

      Key Eligibility Criteria

      Disqualifiers:Rigid Lenses, Poor Hygiene, Others
      Must Not Be Taking:Atropine, Pirenzepine

      144 Participants Needed

      Overnight Orthokeratology Lenses for Near-Sightedness

      New York, New York
      The objective of this clinical investigation is to collect scientifically valid safety and effectiveness data on the Acuity 200™ (fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear. The clinical performance data reported from this study is intended to be submitted to the U.S. Food and Drug Administration Center for Devices and Radiological Health (CDRH) in support of a new Premarket Application (PMA).
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Unphased
      Age:7+

      Key Eligibility Criteria

      Disqualifiers:Pregnancy, Diabetes, Glaucoma, Others
      Must Not Be Taking:Corticosteroids, Atropine

      387 Participants Needed

      Novel Spectacle Lenses for Nearsightedness

      New York, New York
      This is a two-arm parallel group, non-dispensing study. Participants will be existing active CYPRESS Extension (CPRO-1802-002) subjects. Subjects will undergo additional visual performance assessments.

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Unphased
      Age:9 - 14

      Key Eligibility Criteria

      Disqualifiers:Ocular Infection, Inflammation, Irritation

      51 Participants Needed

      Novel Spectacle Lenses for Near-sightedness

      Vestal, New York
      Randomized, controlled, multisite, subject-and observer-masked, 3-arm parallel group clinical trial of 36-month duration to evaluate the safety and efficacy of a novel spectacle lens design in reducing the progression of juvenile myopia.
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Unphased
      Age:6 - 10

      Key Eligibility Criteria

      Disqualifiers:Contact Lenses, Bifocals, Myopia Control, Others

      266 Participants Needed

      Spectacle Lenses for Nearsightedness

      Vestal, New York
      To quantify myopic progression (cycloplegic spherical equivalent refraction - cSER) following the cessation of use of specific spectacle lenses. To quantify axial length progression following cessation of use of specific spectacle lenses.
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Unphased
      Age:9 - 16

      Key Eligibility Criteria

      Disqualifiers:Allergy To Proparacaine, Others

      90 Participants Needed

      New Glasses for Nearsightedness

      Vestal, New York
      This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Unphased
      Age:6 - 17

      Key Eligibility Criteria

      Disqualifiers:Allergy To Proparacaine, Others

      200 Participants Needed

      Delefilcon A Contact Lenses for Refractive Errors

      New York, New York
      The purpose of the study is to evaluate the lens fit characteristics of delefilcon A contact lenses with different base curves and diameters.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased

      Key Eligibility Criteria

      Disqualifiers:Anterior Segment Disease, Refractive Surgery, Irregular Cornea, Others

      190 Participants Needed

      Multifocal Toric Contact Lenses for Astigmatism and Presbyopia

      Garner, North Carolina
      The purpose of this study is to evaluate on-eye clinical performance of the investigational contact lenses following 30 days of wear in the intended population.
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting
      Age:40+

      Key Eligibility Criteria

      Disqualifiers:Not Listed

      88 Participants Needed

      Novel Spectacle Lenses for Myopia

      Athens, Ohio
      This trial is testing a treatment to see how well it works for younger children. The study will look at results over time to predict how effective the treatment will be in the long term. The trial involves multiple sites to ensure accurate results.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:6 - 8

      Key Eligibility Criteria

      Disqualifiers:Contact Lenses, Bifocals, Amblyopia, Others
      Must Not Be Taking:Atropine

      150 Participants Needed

      LASIK vs ICL for Near-sightedness

      Cleveland, Ohio
      Evaluating outcomes after bilateral implantation of ICLs or bilateral LASIK as treatment options for the correction or reduction of myopia with or without astigmatism.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Age:21 - 45

      Key Eligibility Criteria

      Disqualifiers:Pregnancy, Uncontrolled Diabetes, Glaucoma, Others

      56 Participants Needed

      AccuraSee™ Lens for Cataracts

      Cleveland, Ohio
      This is a study to evaluate the safety and effectiveness of the AccuraSee™ intraocular pseudophakic capsular lens (IOPCL) to improve near and/or intermediate vision following previous cataract surgery.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:22+

      Key Eligibility Criteria

      Disqualifiers:Diabetic Retinopathy, Glaucoma, Macular Degeneration, Others
      Must Not Be Taking:Flomax, Others

      10 Participants Needed

      Atropine + Contact Lenses for Near-sightedness

      Columbus, Ohio
      The goal of this clinical trial is to study changes in eye shape of nearsighted young adults using low-dose atropine eye drops or soft multifocal contact lenses. The main questions it aims to answer are: * do low-dose atropine and soft multifocal contact lenses affect the shape of the peripheral eye? * are changes in peripheral eye shape from these interventions influenced by changes in the focusing system of the eye? Participants will: * have multiple different types of photos taken * have their prescription for glasses/contacts checked * have their eye health checked, including the use of dilating eye drops * be randomly assigned to use eye drops every night or wear special contact lenses daily instead of their typical contacts * will complete five study visits over the course of 12 months Researchers will compare young adults using low-dose atropine to those wearing soft multifocal contact lenses and to those using no intervention to see if using these interventions affects retinal shape.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Phase 4
      Age:21 - 30

      Key Eligibility Criteria

      Disqualifiers:Eye Diseases, Pregnancy, Refractive Surgery, Others

      75 Participants Needed

      One-Week Contact Lenses for Near-Sightedness

      Columbus, Ohio
      This open-label study is of current Acuvue® Oasys® wearers (2 - week replacement, reusable lenses) who are satisfied with their current lenses. Subjects will be refit into one week reusable contact lenses and will wear lenses for approximately 2 weeks. Subjects will return for vision and lens fit assessments and will complete surveys about their wear experience.
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Unphased

      Key Eligibility Criteria

      Disqualifiers:Not Listed

      71 Participants Needed

      Why Other Patients Applied

      "I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."

      ZS
      Depression PatientAge: 51

      "I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."

      FF
      ADHD PatientAge: 31

      "I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."

      AG
      Paralysis PatientAge: 50

      "I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."

      WR
      Obesity PatientAge: 58

      "My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."

      HZ
      Arthritis PatientAge: 78
      Match to a Myopia Trial

      Multifocal Contact Lenses for Near-sightedness

      Columbus, Ohio
      The purpose of this study is to compare visual performance (high and low contrast acuity, reading acuity, contrast sensitivity, stereoacuity, accommodative response, eye hand coordination, far near vision, and dynamic vision) between Visioneering Technologies, Inc. NaturalVue Multifocal and CooperVivion MiSight.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:9 - 30

      Key Eligibility Criteria

      Disqualifiers:Autoimmune, Diabetes, Lazy Eye, Others
      Must Not Be Taking:Corticosteroids, Antimetabolites

      30 Participants Needed

      Soft Bifocal Contact Lenses for Near-sightedness

      Columbus, Ohio
      This project intends to provide important, previously unmet answers regarding biological associations with myopia (nearsightedness) progression in order to improve the ability to predict patients who are most likely to benefit from myopia control, as well as questions frequently posed by patients and practitioners about the side effects, mechanism, and discontinuation of soft bifocal contact lens myopia control. The first three aims examine the association between biological variables that can be measured non-invasively and myopia progression, and they will be conducted regardless of the outcome of the currently in progress BLINK Study. The last three specific aims will be conducted if soft bifocal contact lenses slowed myopia progression by 30% or more in the BLINK Study, and they can be investigated with very few additional measurements.
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting
      Age:10 - 15

      Key Eligibility Criteria

      Disqualifiers:Not Listed

      248 Participants Needed

      SHJ002 for Near-sightedness

      Hillsboro, Ohio
      The objective of this study is to explore the safety and efficacy of SHJ002 Sterile Ophthalmic Solution relative to atropine in myopia control SHJ002 is an antisense oligonucleotide to neutralize a specific microRNA.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Phase 2
      Age:3 - 12

      Key Eligibility Criteria

      Disqualifiers:Axial Length > 26 Mm, Anisometropia, Astigmatism > 2.00 D, Others

      144 Participants Needed

      DOT Spectacle Lenses for Nearsightedness

      Waterloo, Ontario
      The objective of the study is to measure the effect of Diffusion Optics Technology (DOT) spectacle lenses on the choroidal thickness and choroidal vascularity index compared to control lenses.
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Unphased
      Age:8 - 14

      Key Eligibility Criteria

      Disqualifiers:Myopia Control, Amblyopia, Diabetes, Others
      Must Not Be Taking:Atropine Eye Drops

      30 Participants Needed

      Novel Spectacle Lenses for Near-sightedness

      Waterloo, Ontario
      Diurnal variations in the thickness of the choroid have been reported in the literature, and, more recently, the role of the choroid has been studied with respect to its role in myopia (near-sightedness) progression.
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Unphased
      Age:6 - 10

      Key Eligibility Criteria

      Disqualifiers:Common Cold, Active Allergies, Fatigue

      10 Participants Needed

      DOT Spectacle Lenses for Nearsightedness

      Waterloo, Ontario
      The objective of the study is to measure the difference in the lag of accommodation between DOT spectacle lenses and control spectacles.
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting
      Trial Phase:Unphased
      Age:6 - 18

      Key Eligibility Criteria

      Disqualifiers:Myopia Control, Amblyopia, Ocular Disease, Others
      Must Not Be Taking:Atropine Eye Drops

      30 Participants Needed

      Soft Contact Lenses for Near-sightedness

      Waterloo, Ontario
      The aim of this study is to evaluate and compare the performance of two soft contact lenses.
      No Placebo Group

      Trial Details

      Trial Status:Active Not Recruiting

      Key Eligibility Criteria

      Disqualifiers:Not Listed

      50 Participants Needed

      Contact Lenses for Astigmatism

      Waterloo, Ontario
      The primary objective of the study is to evaluate and compare the performance of two soft contact lens.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:17 - 42

      Key Eligibility Criteria

      Disqualifiers:Ocular Disease, Allergies, Surgery, Others
      Must Not Be Taking:Systemic Medications

      30 Participants Needed

      Violet Light Therapy for Near-Sightedness

      Cincinnati, Ohio
      This trial uses special violet light lamps to see if they can help slow down the worsening of nearsightedness in children. The study compares these lamps to regular white light lamps, focusing on their effects over time.

      Trial Details

      Trial Status:Recruiting
      Trial Phase:Unphased
      Age:5 - 12

      Key Eligibility Criteria

      Disqualifiers:Strabismus, Amblyopia, Nystagmus, Others
      Must Not Be Taking:Antimuscarinics

      72 Participants Needed

      Contact Lenses for Near-sightedness

      Montreal, Quebec
      The purpose of this study is to gain a better understanding of the retinal vascular changes that occur in response to the optical effect of a myopic defocus daily disposable soft contact lens (MDSL) in a group of healthy young myopic adults (18-35 years; myopia -1.00D to -4.00D; all genders). It will also learn about the acceptance of this visual correction modality compared to regular contact lenses. The main questions to be answered are: * To evaluate changes in retinal blood flow by visualizing retinal vascular density in the superficial and deep plexus after one week of MDSL wear. * To evaluate changes in choroidal thickness at the macular level after one week of MDSL wear. * To evaluate the visual comfort provided by this MDSL design using a questionnaire. Researchers will compare the MDSL to a daily disposable single vision soft lens (SVSL) used to correct myopia to determine if the addition of a defocus area makes a difference in the retinal response to the visual signal. Participants will be required to * Wear both MDSL and SVSL for one week each, in a random order. * Read letters to measure visual acuity * Have a deep scan of their retina with an optical coherence tomography (OCT) device * Rate the comfort and vision provided by both devices using a questionnaire.
      No Placebo Group

      Trial Details

      Trial Status:Recruiting
      Age:18 - 35

      Key Eligibility Criteria

      Disqualifiers:Corneal Dystrophy, Smoking, Pregnancy, Others
      Must Not Be Taking:Blood Pressure Medications

      25 Participants Needed

      12

      Know someone looking for new options?
      Spread the word

      Why We Started Power

      We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.

      Bask
      Bask GillCEO at Power
      Learn More About Trials
      How Do Clinical Trials Work?Are Clinical Trials Safe?What Can I Expect During a Clinical Trial?
      Match to a Trial
      Match to a Trial

      Frequently Asked Questions

      How much do Myopia clinical trials pay?

      Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.

      How do Myopia clinical trials work?

      After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Myopia trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Myopia is 12 months.

      How do I participate in a study as a "healthy volunteer"?

      Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.

      What does the "phase" of a clinical trial mean?

      The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.

      Do I need to be insured to participate in a Myopia medical study?

      Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.

      What are the newest Myopia clinical trials?

      Most recently, we added Delefilcon A Contact Lenses for Refractive Errors, Specialized Contact Lenses for Nearsightedness and Contact Lenses for Astigmatism to the Power online platform.